MASTEC INC (MTZ) Fundamental Analysis & Valuation

NYSE:MTZ • US5763231090

Current stock price

394.05 USD
+23.5 (+6.34%)
At close:
417.6 USD
+23.55 (+5.98%)
Pre-Market:

This MTZ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. MTZ Profitability Analysis

1.1 Basic Checks

  • MTZ had positive earnings in the past year.
  • MTZ had a positive operating cash flow in the past year.
  • MTZ had positive earnings in 4 of the past 5 years.
  • MTZ had a positive operating cash flow in each of the past 5 years.
MTZ Yearly Net Income VS EBIT VS OCF VS FCFMTZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • With a Return On Assets value of 4.02%, MTZ perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
  • With a Return On Equity value of 12.24%, MTZ perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 8.01%, MTZ is in line with its industry, outperforming 58.18% of the companies in the same industry.
  • MTZ had an Average Return On Invested Capital over the past 3 years of 5.53%. This is significantly below the industry average of 14.27%.
  • The 3 year average ROIC (5.53%) for MTZ is below the current ROIC(8.01%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.02%
ROE 12.24%
ROIC 8.01%
ROA(3y)1.77%
ROA(5y)2.06%
ROE(3y)5.33%
ROE(5y)6.03%
ROIC(3y)5.53%
ROIC(5y)5.54%
MTZ Yearly ROA, ROE, ROICMTZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

1.3 Margins

  • MTZ has a Profit Margin (2.79%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of MTZ has declined.
  • MTZ has a Operating Margin (4.62%) which is comparable to the rest of the industry.
  • MTZ's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 12.54%, MTZ is doing worse than 60.00% of the companies in the same industry.
  • MTZ's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.62%
PM (TTM) 2.79%
GM 12.54%
OM growth 3Y11.88%
OM growth 5Y-8.68%
PM growth 3Y101.41%
PM growth 5Y-11.38%
GM growth 3Y0.95%
GM growth 5Y-5.47%
MTZ Yearly Profit, Operating, Gross MarginsMTZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MTZ Health Analysis

2.1 Basic Checks

  • MTZ has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, MTZ has less shares outstanding
  • The number of shares outstanding for MTZ has been increased compared to 5 years ago.
  • The debt/assets ratio for MTZ has been reduced compared to a year ago.
MTZ Yearly Shares OutstandingMTZ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
MTZ Yearly Total Debt VS Total AssetsMTZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • An Altman-Z score of 4.97 indicates that MTZ is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of MTZ (4.97) is better than 70.91% of its industry peers.
  • MTZ has a debt to FCF ratio of 8.16. This is a slightly negative value and a sign of low solvency as MTZ would need 8.16 years to pay back of all of its debts.
  • MTZ has a Debt to FCF ratio of 8.16. This is comparable to the rest of the industry: MTZ outperforms 56.36% of its industry peers.
  • A Debt/Equity ratio of 0.67 indicates that MTZ is somewhat dependend on debt financing.
  • MTZ has a Debt to Equity ratio (0.67) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 8.16
Altman-Z 4.97
ROIC/WACC0.75
WACC10.71%
MTZ Yearly LT Debt VS Equity VS FCFMTZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • MTZ has a Current Ratio of 1.32. This is a normal value and indicates that MTZ is financially healthy and should not expect problems in meeting its short term obligations.
  • MTZ has a Current ratio (1.32) which is in line with its industry peers.
  • MTZ has a Quick Ratio of 1.29. This is a normal value and indicates that MTZ is financially healthy and should not expect problems in meeting its short term obligations.
  • MTZ has a Quick ratio of 1.29. This is comparable to the rest of the industry: MTZ outperforms 56.36% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 1.29
MTZ Yearly Current Assets VS Current LiabilitesMTZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. MTZ Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 63.66% over the past year.
  • MTZ shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.01% yearly.
  • Looking at the last year, MTZ shows a quite strong growth in Revenue. The Revenue has grown by 16.22% in the last year.
  • MTZ shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.73% yearly.
EPS 1Y (TTM)63.66%
EPS 3Y28.74%
EPS 5Y5.01%
EPS Q2Q%172.55%
Revenue 1Y (TTM)16.22%
Revenue growth 3Y13.51%
Revenue growth 5Y17.73%
Sales Q2Q%34.44%

3.2 Future

  • MTZ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.48% yearly.
  • MTZ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.52% yearly.
EPS Next Y31.16%
EPS Next 2Y28.94%
EPS Next 3Y25.96%
EPS Next 5Y22.48%
Revenue Next Year21.14%
Revenue Next 2Y15.53%
Revenue Next 3Y13.63%
Revenue Next 5Y11.52%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MTZ Yearly Revenue VS EstimatesMTZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
MTZ Yearly EPS VS EstimatesMTZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

2

4. MTZ Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 53.03, the valuation of MTZ can be described as expensive.
  • The rest of the industry has a similar Price/Earnings ratio as MTZ.
  • MTZ's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.77.
  • MTZ is valuated quite expensively with a Price/Forward Earnings ratio of 36.18.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MTZ is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.75, MTZ is valued quite expensively.
Industry RankSector Rank
PE 53.03
Fwd PE 36.18
MTZ Price Earnings VS Forward Price EarningsMTZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MTZ is on the same level as its industry peers.
  • MTZ's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 108.71
EV/EBITDA 30.34
MTZ Per share dataMTZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

  • MTZ's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • MTZ's earnings are expected to grow with 25.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.7
PEG (5Y)10.59
EPS Next 2Y28.94%
EPS Next 3Y25.96%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MTZ Dividend Analysis

5.1 Amount

  • No dividends for MTZ!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MTZ Fundamentals: All Metrics, Ratios and Statistics

MASTEC INC

NYSE:MTZ (4/30/2026, 8:06:03 PM)

Premarket: 417.6 +23.55 (+5.98%)

394.05

+23.5 (+6.34%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Industry Strength91.93
Industry Growth91.3
Earnings (Last)04-30
Earnings (Next)N/A
Inst Owners76.42%
Inst Owner Change0.52%
Ins Owners21.42%
Ins Owner Change0.01%
Market Cap31.06B
Revenue(TTM)14.30B
Net Income(TTM)399.04M
Analysts83.08
Price Target375.98 (-4.59%)
Short Float %4.89%
Short Ratio3.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.99%
Min EPS beat(2)5.34%
Max EPS beat(2)6.65%
EPS beat(4)4
Avg EPS beat(4)16.73%
Min EPS beat(4)5.34%
Max EPS beat(4)49.47%
EPS beat(8)8
Avg EPS beat(8)24.65%
EPS beat(12)11
Avg EPS beat(12)17.2%
EPS beat(16)15
Avg EPS beat(16)18%
Revenue beat(2)2
Avg Revenue beat(2)2.85%
Min Revenue beat(2)0.63%
Max Revenue beat(2)5.06%
Revenue beat(4)4
Avg Revenue beat(4)3.21%
Min Revenue beat(4)0.63%
Max Revenue beat(4)5.06%
Revenue beat(8)6
Avg Revenue beat(8)0.58%
Revenue beat(12)7
Avg Revenue beat(12)-0.6%
Revenue beat(16)10
Avg Revenue beat(16)0.16%
PT rev (1m)30.58%
PT rev (3m)33%
EPS NQ rev (1m)0.03%
EPS NQ rev (3m)8.48%
EPS NY rev (1m)1.68%
EPS NY rev (3m)4.25%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)7.93%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)10%
Valuation
Industry RankSector Rank
PE 53.03
Fwd PE 36.18
P/S 2.17
P/FCF 108.71
P/OCF 56.92
P/B 9.53
P/tB 87.73
EV/EBITDA 30.34
EPS(TTM)7.43
EY1.89%
EPS(NY)10.89
Fwd EY2.76%
FCF(TTM)3.62
FCFY0.92%
OCF(TTM)6.92
OCFY1.76%
SpS181.39
BVpS41.35
TBVpS4.49
PEG (NY)1.7
PEG (5Y)10.59
Graham Number83.1386 (-78.9%)
Profitability
Industry RankSector Rank
ROA 4.02%
ROE 12.24%
ROCE 9.93%
ROIC 8.01%
ROICexc 8.52%
ROICexgc 15.9%
OM 4.62%
PM (TTM) 2.79%
GM 12.54%
FCFM 2%
ROA(3y)1.77%
ROA(5y)2.06%
ROE(3y)5.33%
ROE(5y)6.03%
ROIC(3y)5.53%
ROIC(5y)5.54%
ROICexc(3y)5.91%
ROICexc(5y)5.92%
ROICexgc(3y)11.65%
ROICexgc(5y)11.3%
ROCE(3y)6.85%
ROCE(5y)6.87%
ROICexgc growth 3Y28.04%
ROICexgc growth 5Y-3.4%
ROICexc growth 3Y28.13%
ROICexc growth 5Y-4.89%
OM growth 3Y11.88%
OM growth 5Y-8.68%
PM growth 3Y101.41%
PM growth 5Y-11.38%
GM growth 3Y0.95%
GM growth 5Y-5.47%
F-Score8
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 8.16
Debt/EBITDA 2
Cap/Depr 60.87%
Cap/Sales 1.82%
Interest Coverage 3.74
Cash Conversion 50.18%
Profit Quality 71.6%
Current Ratio 1.32
Quick Ratio 1.29
Altman-Z 4.97
F-Score8
WACC10.71%
ROIC/WACC0.75
Cap/Depr(3y)40.75%
Cap/Depr(5y)42.88%
Cap/Sales(3y)1.55%
Cap/Sales(5y)1.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.66%
EPS 3Y28.74%
EPS 5Y5.01%
EPS Q2Q%172.55%
EPS Next Y31.16%
EPS Next 2Y28.94%
EPS Next 3Y25.96%
EPS Next 5Y22.48%
Revenue 1Y (TTM)16.22%
Revenue growth 3Y13.51%
Revenue growth 5Y17.73%
Sales Q2Q%34.44%
Revenue Next Year21.14%
Revenue Next 2Y15.53%
Revenue Next 3Y13.63%
Revenue Next 5Y11.52%
EBIT growth 1Y35.6%
EBIT growth 3Y26.99%
EBIT growth 5Y7.51%
EBIT Next Year111.02%
EBIT Next 3Y42.1%
EBIT Next 5Y29.23%
FCF growth 1Y-70.63%
FCF growth 3Y47.58%
FCF growth 5Y-16.96%
OCF growth 1Y-51.35%
OCF growth 3Y15.7%
OCF growth 5Y-10.25%

MASTEC INC / MTZ Fundamental Analysis FAQ

What is the fundamental rating for MTZ stock?

ChartMill assigns a fundamental rating of 4 / 10 to MTZ.


What is the valuation status for MTZ stock?

ChartMill assigns a valuation rating of 2 / 10 to MASTEC INC (MTZ). This can be considered as Overvalued.


How profitable is MASTEC INC (MTZ) stock?

MASTEC INC (MTZ) has a profitability rating of 4 / 10.


How financially healthy is MASTEC INC?

The financial health rating of MASTEC INC (MTZ) is 5 / 10.